OCHBS Interviews: Chris Biggar: Quality Assurance: Open Book Extracts
Latest News
atai Life Sciences Initiates Phase 2 Trial of EMP-01 for Social Anxiety Disorder
LOS ANGELES- atai Life Sciences has commenced a Phase 2 clinical trial evaluating EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine (R-MDMA), for the treatment of social anxiety disorder (SAD). The first patient has been dosed in ...
Village Farms International Reports Q1 2025
LOS ANGELES- Village Farms International Inc. has announced its financial results for the first quarter of 2025, highlighting a strategic pivot towards its cannabis operations and the privatization of certain fresh produce assets. For the ...
Legalization Significantly Reduces Canada’s Illicit Cannabis Market
LOS ANGELES- Recent analyses indicate that Canada's legalization of non-medical cannabis in 2018 has substantially shifted consumer spending from illicit to legal markets. Studies report that within five years of legalization, approximately 75% of cannabis ...